It's a new era for Alabama football, as Kalen DeBoer takes over for Nick Saban. The Crimson Tide's road this year features another grueling SEC slate with compelling out-of-conference matchups.

Highlights,Corcept Therapeutics (CORT) shares increased by 5.5% in the latest trading session, closing at $49.75, driven by ...

One week after suffering a stunning loss at Vanderbilt, No. 7 Alabama did just enough to keep its College Football Playoff hopes alive Saturday in a stomach-twisting 27-25 win over South Carolina.

Investors should invest in CORT right now as the stock is doing extremely well in 2024 and its prospects look even brighter. As the U.S. stock market experiences a surge, led by a rally in the ...

Vandana Singh Corcept Moves 6.5% Higher: Will This Strength Last? Corcept Therapeutics (NASDAQ: CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by ...

TUSCALOOSA, Ala. — What’s the identity of the 2024 Alabama team? It’s hard to say exactly, which is part of the problem that has led to two losses in the past three weeks. Saturday’s home ...

Correction: This story was updated to adjust South Carolina's third-down conversions and the turnovers forced by Alabama. After losing to Vanderbilt for the first time since 1984 last week ...

Oct 12, 2024; Tuscaloosa, Alabama, USA; Alabama Crimson Tide wide receiver Germie Bernard (5) scores a touchdown against the South Carolina Gamecocks during the fourth quarter at Bryant-Denny Stadium.

TUSCALOOSA, Ala. -- Alabama was pushed to the brink of a second straight Southeastern Conference upset loss. This time the Crimson Tide survived, if only barely. No. 7 Alabama (5-1, 2-1 ...

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...